![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
(MM) | NASDAQ:IDIX | NASDAQ | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 24.50 | 0.00 | 01:00:00 |
Delaware
|
000-49839
|
45-0478605
|
(State
or other jurisdiction of incorporation or organization)
|
(Commission
File Number)
|
(I.R.S.
Employer Identification
No.)
|
60
Hampshire Street
Cambridge,
MA
|
02139
|
(Address
of principal executive offices)
|
(Zip
Code)
|
r
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
r
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
r
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
r
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item
5.02
|
Departure of Directors or
Principal Officers; Election of Directors; Appointment of Principal
Officers; Compensatory Arrangements of Certain
Officers
|
•
|
agreed
to use its reasonable best efforts to nominate for election as a director
at least two designees of Novartis for so long as Novartis and its
affiliates own at least 35% of Idenix’s voting stock and at least one
designee of Novartis for so long as Novartis and its affiliates own at
least 19.4% of Idenix’s voting stock; and
|
|
•
|
agreed
that for so long as any designee of Novartis serves on the Board, a
Novartis director designee is entitled to be a member of each committee of
the Board or a non-voting observer to any such committee, if such
committee membership is barred by applicable law, rule or
regulation.
|
|
IDENIX PHARMACEUTICALS, INC. | |||
Date: June
3, 2009
|
By:
|
/s/ Ronald C. Renaud, Jr. | |
Ronald C. Renaud, Jr. | |||
Chief Financial Officer and Treasurer | |||
Exhibit No.
|
Description
|
99.1
|
S-3
Financing Waiver and Consent dated May 19,
2009.
|
1 Year (MM) Chart |
1 Month (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions